Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne
Status:
Completed
Trial end date:
2011-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the efficacy and safety of CIP-Isotretinoin and a
marketed (generic) formulation of isotretinoin when both are administered twice daily with
meals.